Pharmacovigilance Global Market Opportunities And Strategies To 2032

Pharmacovigilance Market 2023 – By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Contract Outsourcing), By End-User (Hospitals, Pharmaceutical Companies, Other End-Users), By Clinical Trial Phases (Preclinical, Phase I, Phase II, Phase III, Phase IV), By Process Flow (Case Data Management, Signal Detection, Risk Management System), And By Region, Opportunities And Strategies – Global Forecast To 2032

Starting Price : $5000.00 $3350.00 | Pages : 305 | Published : November 2023 | | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Pharmacovigilance Global Market Opportunities And Strategies To 2032

Proud Members Of

checkslacipN checkaoirsN checkscipN

Pharmacovigilance Market Definition

The pharmacovigilance market consists of sales of pharmacovigilance services by entities (organizations, sole traders, and partnerships) that collect, assess, and distribute drug safety and efficacy data.

The term "pharmacovigilance" is derived from the combination of "pharmaco," relating to drugs or pharmaceuticals, and "vigilance," which means the action or state of being watchful and alert.  Pharmacovigilance (PV), also known as drug safety, is the process of monitoring, detecting, assessing, and preventing adverse effects or any other drug-related problems to ensure the safe use of pharmaceutical products.

Pharmacovigilance Market Size

The global pharmacovigilance market reached a value of nearly $6,715.5 million in 2022, having increased at a compound annual growth rate (CAGR) of 8.5% since 2017. The market is expected to grow from $6,715.5 million in 2022 to $12,569.8 million in 2027 at a rate of 13.4%. The market is then expected to grow at a CAGR of 12.3% from 2027 and reach $22,416.8 million in 2032.  

Growth in the historic period resulted from the increasing incidence of adverse drug reactions (ADRs), the increasing research and development (R&D) activities, the growing drug development rates, the increasing focus on personalized medicine and the rising prevalence of chronic diseases. Factors that negatively affected growth in the historic period were risks associated with securing data, the lack of awareness of the importance of pharmacovigilance and low healthcare access in developing countries.

Going forward, the rising healthcare expenditure, the increasing government support and the aging population will drive the market. Factors that could hinder the growth of the pharmacovigilance market in the future include regulatory challenges and the high cost of implementation.

Pharmacovigilance Market Drivers

The key drivers of the pharmacovigilance market include:

Rising Healthcare Expenditure

The rising healthcare expenditure will drive the growth of the pharmacovigilance market in the forecast period. With increased funding, healthcare systems can invest in advanced technologies, data analytics, and dedicated teams of experts to efficiently identify and assess adverse drug reactions. Additionally, higher healthcare spending allows for better training and education of healthcare professionals on pharmacovigilance practices, ensuring timely reporting and analysis of potential drug-related issues. For example, according to the Centers for Medicare & Medicaid Services, a US-based federal healthcare agency, the average National Health Expenditures (NHE) growth (5.4%) is projected to exceed average GDP growth (4.6%) between 2022 and 2031, resulting in an increase in the health-spending share of GDP from 18.3% in 2021 to 19.6% in 2031 . Additionally, in April 2022, according to a report published by the National Association of Chronic Disease Directors (NACDD), a US-based non-profit Public Health organization dedicated to chronic disease programs, almost 60 percent of adult Americans have at least one chronic disease, and approximately 40% of American adults have multiple chronic conditions (MCC), and this is expected to cost the US economy $2 trillion annually, or $8,600 per person by 2030 . Thus, the rising healthcare expenditure will propel the growth of the pharmacovigilance market going forward.

Pharmacovigilance Market Restraints

The key restraints on the pharmacovigilance market include:

High Cost Of Implementation

The high cost of implementation can have a negative impact on the pharmacovigilance market's growth and expansion. Pharmacovigilance is a crucial process that involves collecting, analyzing, and evaluating data on the adverse effects of medications to ensure their safe use.   However, setting up and maintaining a robust pharmacovigilance system requires significant financial investments, including the establishment of databases, training of staff, and implementation of surveillance programs.   If an organization or health authority lacks adequate funding, it may lead to insufficient staffing, outdated technologies, and reduced capacity to detect and respond to emerging safety concerns effectively.  As a result, potential risks associated with drugs may go unnoticed or underreported, jeopardizing patient safety and public health.   Therefore, the high cost of implementation is expected to have a negative impact on the market.

Pharmacovigilance Market Trends

Major trends influencing the pharmacovigilance market include:

Focus On Innovative Cloud-Based Systems

Companies in the pharmacovigilance market are focusing on innovative cloud-based systems to strengthen their position in the market. Cloud-based systems can help the pharmaceutical industry become more efficient, cost-effective, and innovative. By utilizing cloud computing, pharma companies can streamline their processes, improve data management, and accelerate drug discovery, ultimately leading to better patient outcomes. For example, in February 2019, ICON plc, an Ireland-based company that provides drug development solutions and services to the pharmaceutical, biotechnology and medical device industries released a new drug safety reporting solution based on an innovative cloud-based system, featuring automated and configurable business rules. The technology guarantees compliance in an increasingly complex regulatory environment and gives the sponsor visibility into the investigational product's safety profile over the course of its lifecycle. The system has additional reporting capabilities and a dashboard that displays submissions individually and collectively at the study and portfolio levels. This gives the sponsor more transparency to oversee and monitor drug safety.

Strategic Mergers And Acquisitions

Strategic mergers and acquisitions are gaining popularity in the pharmacovigilance market. Major companies operating in the pharmacovigilance market are focusing on strategic mergers and acquisitions to strengthen their product portfolio and to expand their geographic presence. For example, in January 2023, AmerisourceBergen, a US-based drug wholesale company, acquired Pharma Lex for an undisclosed amount. This acquisition is expected to add capabilities to the company's existing service offering, allowing the company to provide pharmaceutical and biotech companies with enhanced support and value across the product lifecycle. Pharma Lex’s Germany-based team provides true end-to-end solutions for pharmacovigilance systems and operations, as well as benefit-risk management services.  Also, in November 2020, Veristat, a US-based scientific-minded global clinical research organization, acquired Certus PV Services Inc. for an undisclosed amount. This acquisition is expected to support Veristat’s focus on meeting client demands and offering quality services across the entire drug development journey. Certus PV, a Canada-based company, offers pre-approval and post-marketing pharmacovigilance and safety monitoring support for drug developers.

Opportunities And Recommendations In The Pharmacovigilance Market

Opportunities –The top opportunities in the pharmacovigilance market by type will arise in the spontaneous reporting market, which will gain $1,974.8 million of global annual sales by 2027. The top opportunities in the pharmacovigilance market by service provider will arise in the contract outsourcing market, which will gain $3,510.1 million of global annual sales by 2027. The top opportunities in the pharmacovigilance market by end user will arise in the pharmaceutical companies market, which will gain $2,841.8 million of global annual sales by 2027. The top opportunities in the pharmacovigilance market by clinical trial phases will arise in the phase IV market, which will gain $4,276.6 million of global annual sales by 2027. The top opportunities in the pharmacovigilance market by process flow will arise in the signal detection market, which will gain $2,243.6 million of global annual sales by 2027. The pharmacovigilance market size will gain the most in the USA at $2,146.6 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the pharmacovigilance companies to focus on innovative cloud-based systems, focus on artificial intelligence, focus on innovative platforms, focus on fast-growing service types, expand in emerging markets, continue to focus on developed markets, focus on strategic mergers and acquisitions, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions and  continue to target fast-growing end-use industries.

Pharmacovigilance Market Segmentation

The pharmacovigilance market is segmented by type, by service provider, by end-user, by clinical trial phases and by process flow.
By Type -
The pharmacovigilance market is segmented by type into
    • a) Spontaneous Reporting
    • b) Intensified ADR Reporting
    • c) Targeted Spontaneous Reporting
    • d) Cohort Event Monitoring
    • e) EHR Mining
The spontaneous reporting market was the largest segment of the pharmacovigilance market by type, accounting for $2,204.2 million or 32.8% of the total market in 2022. The targeted spontaneous reporting market is expected to be the fastest-growing segment going forward at a CAGR of 13.8%.
By Service Provider -
The pharmacovigilance market is also segmented by service provider into
    • a) In-House
    • b) Contract Outsourcing
The contract outsourcing market was the largest segment of the pharmacovigilance market by service provider, accounting for $3,993.0 million or 59.9% of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 13.4%.
By End-User -
The pharmacovigilance market is also segmented by end-user into
    • a) Hospitals
    • b) Pharmaceutical Companies
    • c) Other End Users
The pharmaceutical companies market was the largest segment of the pharmacovigilance market by end user, accounting for $3,226.9 million or 48.1% of the total market in 2022. The hospitals market is expected to be the fastest-growing segment going forward at a CAGR of 13.8%.
By Clinical Trial Phases -
The pharmacovigilance market is also segmented by clinical trial phases into
    • a) Preclinical
    • b) Phase I
    • c) Phase II
    • d) Phase III
    • e) Phase IV
The phase IV market was the largest segment of the pharmacovigilance market by clinical trial phases, accounting for $4,895.8 million or 72.9% of the total market in 2022. The phase III market is expected to be the fastest-growing segment going forward at a CAGR of 13.6%.
By Process Flow -
The pharmacovigilance market is also segmented by process flow into
    • a) Case Data Management
    • b) Signal Detection
    • c) Risk Management System
The signal detection market was the largest segment of the pharmacovigilance market by process flow, accounting for $2,578.7 million or 38.4% of the total market in 2022. The case data management market is expected to be the fastest-growing segment going forward at a CAGR of 14.1%.
By Geography - The pharmacovigilance market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the pharmacovigilance market, accounting for 44.0% of the global market in 2022. It was followed by Asia-Pacific, Western Europe and the other regions. Going forward, the fastest growing regions in the pharmacovigilance market will be Eastern Europe and Asia-Pacific, where growth will be at CAGRs of 15.8% and 15.0% respectively from 2022-2027.

Pharmacovigilance Market Competitive Landscape

Major Competitors are:

  • IQVIA
  • Cognizant
  • ICON Plc.
  • Accenture plc
  • PAREXEL International Corporation
  • Other Competitors Include:

  • United BioSource LLC
  • ArisGlobal
  • Quanticate
  • Wipro Limited
  • Linical Americas
  • QuintilesIMS
  • Novotech
  • Covance
  • PPD
  • BeiGene
  • Wuxi Apptec
  • Simcere Pharmaceutical Group
  • Lee's Pharmaceutical Holdings
  • Luye Pharma Group
  • PRA Health Sciences
  • Synowledge
  • EXTEDO
  • Arriello
  • PrimeVigilance
  • RAPAhub
  • illuminate health
  • Secure AI Labs
  • OmniSol dot Tech
  • Invenio
  • Canna Call Company
  • Veripad
  • Prevnos Inc.
  • Lifescient, Inc
  • Endo International
  • ClinChoice
  • MSD
  • Novasyte
  • Fortrea
  • Syneos Health Clinical
  • Axios International
  • Zoetis
  • Gilead Science
  • C3i Solutions
  • Spimaco
  • Teva
  • Elanco
  • Alcon
  • Abbott Laboratories
  • DSV
  • Novasyte
    1. Table Of Contents

      1. Executive Summary

      2. Table Of Contents

      3. List Of Figures

      4. List Of Tables

      5. Report Structure

      6. Introduction And Market Characteristics

      6.1. General Market Definition

      6.2. Summary

      6.3. Pharmacovigilance Market Definition And Segmentations

      6.4. Market Segmentation By Type

      6.4.1. Spontaneous Reporting

      6.4.2. Intensified ADR Reporting

      6.4.3. Targeted Spontaneous Reporting

      6.4.4. Cohort Event Monitoring

      6.4.5. EHR Mining

      6.5. Market Segmentation By Service Provider

      6.5.1. In-House

      6.5.2. Contract Outsourcing

      6.6. Market Segmentation By Process Flow

      6.6.1. Case Data Management

      6.6.2. Signal Detection

      6.6.3. Risk Management System

      6.7. Market Segmentation By Clinical Trial Phases

      6.7.1. Preclinical

      6.7.2. Phase I

      6.7.3. Phase II

      6.7.4. Phase III

      6.7.5. Phase IV

      6.8. Market Segmentation By End User

      6.8.1. Hospitals

      6.8.2. Pharmaceutical Companies

      6.8.3. Other End Users

      7. Pharmacovigilance Market - Macro Economic Scenario

      7.1. COVID-19 Impact On The Pharmacovigilance Market

      7.2. Russia-Ukraine War Impact On The Pharmacovigilance Market

      7.3. Impact Of High Inflation On The Pharmacovigilance Market

      8. Major Market Trends

      8.1. Increasing Investments

      8.2. Focus On Artificial Intelligence

      8.3. Focus On Innovative Platforms

      8.4. Focus On Innovative Cloud-Based Systems

      8.5. Strategic Mergers And Acquisitions

      9. Global Market Size and Growth

      9.1. Market Size

      9.2. Historic Market Growth, 2017 – 2022, Value ($ Million)

      9.2.1. Market Drivers 2017 – 2022

      9.2.2. Market Restraints 2017 – 2022

      9.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      9.3.1. Market Drivers 2022 – 2027

      9.3.2. Market Restraints 2022 – 2027

      10. Global Pharmacovigilance Market Segmentation

      10.1. Global Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10.2. Global Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10.3. Global Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10.4. Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      10.5. Global Pharmacovigilance Market, Segmentation By Process Flow, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11. Pharmacovigilance Market, Regional and Country Analysis

      11.1. Global Pharmacovigilance Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      11.2. Global Pharmacovigilance Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12. Asia-Pacific Market

      12.1. Summary

      12.2. Market Overview

      12.2.1. Region Information

      12.2.2. Market Information

      12.2.3. Background Information

      12.2.4. Government Initiatives

      12.2.5. Regulations

      12.2.6. Regulatory Bodies

      12.2.7. Major Associations

      12.2.8. Taxes Levied

      12.2.9. Corporate Tax Structure

      12.2.10. Investments

      12.2.11. Major Companies

      12.3. Asia-Pacific Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.4. Asia-Pacific Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.5. Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.6. Asia-Pacific Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.7. Asia-Pacific Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.8. Asia-Pacific Pharmacovigilance Market: Country Analysis

      12.9. China Market

      12.10. Summary

      12.11. Market Overview

      12.11.1. Country Information

      12.11.2. Market Information

      12.11.3. Background Information

      12.11.4. Government Initiatives

      12.11.5. Regulations

      12.11.6. Regulatory Bodies

      12.11.7. Major Associations

      12.11.8. Taxes Levied

      12.11.9. Corporate Tax Structure

      12.11.10. Investments

      12.11.11. Major Companies

      12.12. China Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.13. China Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.14. China Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.15. China Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.16. China Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.17. India Market

      12.18. India Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.19. India Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.20. India Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.21. India Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.22. India Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.23. Japan Market

      12.24. Japan Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.25. Japan Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.26. Japan Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.27. Japan Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.28. Japan Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.29. Australia Market

      12.30. Australia Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.31. Australia Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.32. Australia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.33. Australia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.34. Australia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.35. Indonesia Market

      12.36. Indonesia Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.37. Indonesia Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.38. Indonesia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.39. Indonesia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.40. Indonesia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.41. South Korea Market

      12.42. South Korea Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      12.43. South Korea Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      12.44. South Korea Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.45. South Korea Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      12.46. South Korea Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13. Western Europe Market

      13.1. Summary

      13.2. Market Overview

      13.2.1. Region Information

      13.2.2. Market Information

      13.2.3. Background Information

      13.2.4. Government Initiatives

      13.2.5. Regulations

      13.2.6. Regulatory Bodies

      13.2.7. Major Associations

      13.2.8. Taxes Levied

      13.2.9. Corporate Tax Structure

      13.2.10. Investments

      13.2.11. Major Companies

      13.3. Western Europe Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.4. Western Europe Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.5. Western Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.6. Western Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.7. Western Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.8. Western Europe Pharmacovigilance Market: Country Analysis

      13.9. UK Market

      13.10. UK Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.11. UK Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.12. UK Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.13. UK Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.14. UK Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.15. Germany Market

      13.16. Germany Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.17. Germany Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.18. Germany Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.19. Germany Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.20. Germany Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.21. France Market

      13.22. France Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      13.23. France Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      13.24. France Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.25. France Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      13.26. France Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14. Eastern Europe Market

      14.1. Summary

      14.2. Market Overview

      14.2.1. Region Information

      14.2.2. Market Information

      14.2.3. Background Information

      14.2.4. Government Initiatives

      14.2.5. Regulations

      14.2.6. Regulatory Bodies

      14.2.7. Major Associations

      14.2.8. Taxes Levied

      14.2.9. Corporate Tax Structure

      14.2.10. Investments

      14.2.11. Major Companies

      14.3. Eastern Europe Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.4. Eastern Europe Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.5. Eastern Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.6. Eastern Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.7. Eastern Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.8. Eastern Europe Pharmacovigilance Market: Country Analysis

      14.9. Russia Market

      14.10. Russia Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      14.11. Russia Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      14.12. Russia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.13. Russia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      14.14. Russia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15. North America Market

      15.1. Summary

      15.2. Market Overview

      15.2.1. Region Information

      15.2.2. Market Information

      15.2.3. Background Information

      15.2.4. Government Initiatives

      15.2.5. Regulations

      15.2.6. Regulatory Bodies

      15.2.7. Major Associations

      15.2.8. Taxes Levied

      15.2.9. Corporate Tax Structure

      15.2.10. Investments

      15.2.11. Major Companies

      15.3. North America Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.4. North America Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.5. North America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.6. North America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.7. North America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.8. North America Pharmacovigilance Market: Country Analysis

      15.9. USA Market

      15.10. Summary

      15.11. Market Overview

      15.11.1. Country Information

      15.11.2. Market Information

      15.11.3. Background Information

      15.11.4. Government Initiatives

      15.11.5. Regulations

      15.11.6. Regulatory Bodies

      15.11.7. Major Associations

      15.11.8. Taxes Levied

      15.11.9. Corporate Tax Structure

      15.11.10. Investments

      15.11.11. Major Companies

      15.12. USA Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      15.13. USA Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      15.14. USA Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.15. USA Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      15.16. USA Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16. South America Market

      16.1. Summary

      16.2. Market Overview

      16.2.1. Region Information

      16.2.2. Market Information

      16.2.3. Background Information

      16.2.4. Government Initiatives

      16.2.5. Regulations

      16.2.6. Regulatory Bodies

      16.2.7. Major Associations

      16.2.8. Taxes Levied

      16.2.9. Corporate Tax Structure

      16.2.10. Major Companies

      16.3. South America Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      16.4. South America Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      16.5. South America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.6. South America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.7. South America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.8. South America Pharmacovigilance Market: Country Analysis

      16.9. Brazil Market

      16.10. Brazil Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      16.11. Brazil Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      16.12. Brazil Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.13. Brazil Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      16.14. Brazil Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17. Middle East Market

      17.1. Summary

      17.2. Market Overview

      17.2.1. Region Information

      17.2.2. Market Information

      17.2.3. Background information

      17.2.4. Government Initiatives

      17.2.5. Regulations

      17.2.6. Regulatory Bodies

      17.2.7. Major Associations

      17.2.8. Taxes Levied

      17.2.9. Corporate Tax Structure

      17.2.10. Investments

      17.2.11. Major Companies

      17.3. Middle East Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      17.4. Middle East Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      17.5. Middle East Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.6. Middle East Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      17.7. Middle East Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      18. Africa Market

      18.1. Summary

      18.2. Market Overview

      18.2.1. Region Information

      18.2.2. Market Information

      18.2.3. Background Information

      18.2.4. Government Initiatives

      18.2.5. Regulations

      18.2.6. Regulatory Bodies

      18.2.7. Major Associations

      18.2.8. Taxes Levied

      18.2.9. Corporate Tax Structure

      18.2.10. Investments

      18.2.11. Major Companies

      18.3. Africa Pharmacovigilance Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

      18.4. Africa Pharmacovigilance Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

      18.5. Africa Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      18.6. Africa Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      18.7. Africa Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

      19. Competitive Landscape and Company Profiles

      19.1. Company Profiles

      19.2. IQVIA Holdings, Inc

      19.2.1. Company Overview

      19.2.2. Products And Services

      19.2.3. Business Strategy

      19.2.4. Financial Overview

      19.3. Cognizant Technology Solutions Corporation

      19.3.1. Company Overview

      19.3.2. Products And Services

      19.3.3. Business Strategy

      19.3.4. Financial Overview

      19.4. ICON Plc

      19.4.1. Company Overview

      19.4.2. Products And Services

      19.4.3. Business Strategy

      19.4.4. Financial Overview

      19.5. Accenture plc

      19.5.1. Company Overview

      19.5.2. Products And Services

      19.5.3. Business Strategy

      19.5.4. Financial Overview

      19.6. PAREXEL International Corporation

      19.6.1. Company Overview

      19.6.2. Products And Services

      19.6.3. Financial Overview

      20. Key Mergers And Acquisitions

      20.1. AmerisourceBergen Acquired Pharma Lex

      20.2. Clinigen Limited Acquired Drug Safety Navigator Inc

      20.3. Drug Safety and Pharmacovigilance Services Solutions (DSS) Acquired MyMeds&Me

      20.4. TriNetX Acquired Advera Health Analytics

      20.5. Stanley Capital Partners Acquired Drug Safety and Pharmacovigilance Services Solutions

      20.6. Ergomed plc Acquired Ashfield Pharmacovigilance Inc

      21. Opportunities And Strategies

      21.1. Global Pharmacovigilance Market In 2027 – Countries Offering Most New Opportunities

      21.2. Global Pharmacovigilance Market In 2027 – Segments Offering Most New Opportunities

      21.3. Global Pharmacovigilance Market In 2027 – Growth Strategies

      21.3.1. Market Trend Based Strategies

      21.3.2. Competitor Strategies

      22. Pharmacovigilance Market, Conclusions And Recommendations

      22.1. Conclusions

      22.2. Recommendations

      22.2.1. Product

      22.2.2. Place

      22.2.3. Price

      22.2.4. Promotion

      22.2.5. People

      23. Appendix

      23.1. Market Data Sources

      23.2. Research Methodology

      23.3. Currencies

      23.4. The Business Research Company

      23.5. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 2: Global Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 3: Global Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 4: Global Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 5: Global Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 6: Global Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 7: Global Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 8: Global Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 9: Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 10: Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 11: Global Pharmacovigilance Market, Segmentation By Process Flow, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 12: Global Pharmacovigilance Market, Segmentation By Process Flow, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 13: Global Pharmacovigilance Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 14: Global Pharmacovigilance Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 15: Global Pharmacovigilance Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 16: Global Pharmacovigilance Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 17: Asia-Pacific GDP Per Capita, By Country, 2017-2022, $
    • Table 18:  Asia-Pacific Population, By Country, 2017-2027, Millions
    • Table 19: Asia-Pacific, Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 20: Asia-Pacific Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 21: Asia-Pacific Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 22: Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 23: Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 24: Asia-Pacific Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 25: Asia-Pacific Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 26: Asia-Pacific Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 27: Asia-Pacific Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 28: China GDP Per Capita, 2017-2022, $
    • Table 29:  China Population, 2017-2027, Millions
    • Table 30: China Pharmaceuticals Market Size, 2017-2027, $ Billion
    • Table 31: China Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 32: China Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 33: China Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 34: China Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 35: China Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 36: China Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 37: China Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 38: China Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 39: India Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 40: India Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 41: India Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 42: India Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 43: India Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 44: India Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 45: India Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 46: India Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 47: Japan Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 48: Japan Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 49: Japan Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 50: Japan Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 51: Japan Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 52: Japan Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 53: Japan Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 54: Japan Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 55: Australia Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 56: Australia Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 57: Australia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 58: Australia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 59: Australia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 60: Australia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 61: Australia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 62: Australia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 63: Indonesia Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 64: Indonesia Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 65: Indonesia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 66: Indonesia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 67: Indonesia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 68: Indonesia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 69: Indonesia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 70: Indonesia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 71: South Korea Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 72: South Korea Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 73: South Korea Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 74: South Korea Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 75: South Korea Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 76: South Korea Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 77: South Korea Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 78: South Korea Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 79: Western Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 80:  Western Europe Population, By Country, 2017-2027, Millions
    • Table 81: Western Europe Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 82: Western Europe Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 83: Western Europe Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 84: Western Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 85: Western Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 86: Western Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 87: Western Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 88: Western Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 89: Western Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 90: UK Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 91: UK Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 92: UK Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 93: UK Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 94: UK Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 95: UK Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 96: UK Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 97: UK Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 98: Germany Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 99: Germany Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 100: Germany Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 101: Germany Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 102: Germany Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 103: Germany Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 104: Germany Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 105: Germany Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 106: France Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 107: France Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 108: France Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 109: France Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 110: France Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 111: France Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 112: France Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 113: France Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 114: Eastern Europe GDP Per Capita, By Country, 2017-2022, $
    • Table 115:  Eastern Europe Population, By Country, 2017-2027, Millions
    • Table 116: Eastern Europe Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 117: Eastern Europe Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 118: Eastern Europe Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 119: Eastern Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 120: Eastern Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 121: Eastern Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 122: Eastern Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 123: Eastern Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 124: Eastern Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 125: Russia Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 126: Russia Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 127: Russia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 128: Russia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 129: Russia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 130: Russia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 131: Russia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 132: Russia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 133: North America GDP Per Capita, By Country, 2017-2022, $
    • Table 134:  North America Population, By Country, 2017-2027, Millions
    • Table 135: North America Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 136: North America Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 137: North America Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 138: North America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 139: North America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 140: North America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 141: North America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 142: North America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 143: North America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 144: USA GDP Per Capita, 2017-2022, $
    • Table 145:  USA Population, 2017-2027, Millions
    • Table 146: USA Pharmaceuticals Market Size, 2017-2027, $ Billion
    • Table 147: USA Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 148: USA Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 149: USA Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 150: USA Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 151: USA Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 152: USA Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 153: USA Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 154: USA Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 155: South America GDP Per Capita, By Country, 2017-2022, $
    • Table 156:  South America Population, By Country, 2017-2027, Millions
    • Table 157: South America Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 158: South America Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 159: South America Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 160: South America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 161: South America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 162: South America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 163: South America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 164: South America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 165: South America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 166: Brazil Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 167: Brazil Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 168: Brazil Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 169: Brazil Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 170: Brazil Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 171: Brazil Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 172: Brazil Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 173: Brazil Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 174: Middle East GDP Per Capita, By Country, 2017-2022, $
    • Table 175:  Middle East Population, By Country, 2017-2027, Millions
    • Table 176: Middle East Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 177: Middle East Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 178: Middle East Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 179: Middle East Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 180: Middle East Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 181: Middle East Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 182: Middle East Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 183: Middle East Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 184: Middle East Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 185: Africa GDP Per Capita, By Country, 2017-2022, $
    • Table 186:  Africa Population, By Country, 2017-2027, Millions
    • Table 187: Africa Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion
    • Table 188: Africa Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Table 189: Africa Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Table 190: Africa Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 191: Africa Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 192: Africa Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 193: Africa Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 194: Africa Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Table 195: Africa Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million
    • Table 196: Global Pharmacovigilance Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Table 197: IQVIA – Financial Overview, 2018 – 2022, $ Billion
    • Table 198: Cognizant – Financial Performance, 2018 – 2022, $ Billion
    • Table 199: ICON – Financial Overview, 2018 – 2022, $ Billion
    • Table 200: Accenture – Financial Performance, 2018 – 2022, $ Billion
    • Table 201: PAREXEL – Financial Performance, 2022, $ Billion
    • Table 202: Global Pharmacovigilance Market Size Gain ($ Million), 2022 – 2027, By Country
    • Table 203: Global Pharmacovigilance Market Size Gain ($ Million), Segmentation By Type, 2022 – 2027
    • Table 204: Global Pharmacovigilance Market Size Gain ($ Million), Segmentation By Service Provider, 2022 – 2027
    • Table 205: Global Pharmacovigilance Market Size Gain ($ Million), Segmentation By End User, 2022 – 2027
    • Table 206: Global Pharmacovigilance Market Size Gain ($ Million), Segmentation By Clinical Trial Phases, 2022 – 2027
    • Table 207: Global Pharmacovigilance Market Size Gain ($ Million), Segmentation By Process Flow, 2022 – 2027
    • Table 208: Pharmacovigilance Market Data Sources

    List Of Figures

      Figure 1: Geographic Regions Covered
    • Figure 2: Global Pharmacovigilance Market Segmentation By Type
    • Figure 3: Global Pharmacovigilance Market Segmentation By Service Provider
    • Figure 4: Global Pharmacovigilance Market Segmentation By Process Flow
    • Figure 5: Global Pharmacovigilance Market Segmentation By Clinical Trial Phases
    • Figure 6: Global Pharmacovigilance Market Segmentation By End User
    • Figure 7: Global Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 8: Global Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 9: Global Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 10: Global Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 11: Global Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 12: Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 13: Global Pharmacovigilance Market, Segmentation By Process Flow, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 14: Global Pharmacovigilance Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 15: Global Pharmacovigilance Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 16: Asia-Pacific Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 17: Asia-Pacific Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 18: Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 19: Asia-Pacific Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 20: Asia-Pacific Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 21: China Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 22: China Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 23: China Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 24: China Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 25: China Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 26: India Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 27: India Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 28: India Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 29: India Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 30: India Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 31: Japan Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 32: Japan Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 33: Japan Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 34: Japan Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 35: Japan Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 36: Australia Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 37: Australia Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 38: Australia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 39: Australia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 40: Australia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 41: Indonesia Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 42: Indonesia Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 43: Indonesia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 44: Indonesia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 45: Indonesia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 46: South Korea Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 47: South Korea Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 48: South Korea Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 49: South Korea Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 50: South Korea Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 51: Western Europe Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 52: Western Europe Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 53: Western Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 54: Western Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 55: Western Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 56: UK Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 57: UK Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 58: UK Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 59: UK Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 60: UK Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 61: Germany Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 62: Germany Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 63: Germany Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 64: Germany Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 65: Germany Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 66: France Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 67: France Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 68: France Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 69: France Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 70: France Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 71: Eastern Europe Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 72: Eastern Europe Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 73: Eastern Europe Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 74: Eastern Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 75: Eastern Europe Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 76: Russia Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 77: Russia Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 78: Russia Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 79: Russia Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 80: Russia Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 81: North America Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 82: North America Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 83: North America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 84: North America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 85: North America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 86: USA Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 87: USA Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 88: USA Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 89: USA Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 90: USA Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 91: South America Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 92: South America Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 93: South America Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 94: South America Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 95: South America Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 96: Brazil Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 97: Brazil Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 98: Brazil Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 99: Brazil Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 100: Brazil Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 101: Middle East Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 102: Middle East Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 103: Middle East Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 104: Middle East Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 105: Middle East Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 106: Africa Pharmacovigilance Market, Historic, 2017 – 2022, $ Million
    • Figure 107: Africa Pharmacovigilance Market, Forecast, 2022 – 2027, 2032F, $ Million
    • Figure 108: Africa Pharmacovigilance Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 109: Africa Pharmacovigilance Market, Segmentation By Service Provider, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 110: Africa Pharmacovigilance Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %
    • Figure 111: Global Pharmacovigilance Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Figure 112: IQVIA – Financial Overview, 2018 – 2022, $ Billion
    • Figure 113: Cognizant – Financial Performance, 2018 – 2022, $ Billion
    • Figure 114: ICON – Financial Overview, 2018 – 2022, $ Billion
    • Figure 115: Accenture – Financial Performance, 2018 – 2022, $ Billion
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report